Nanoparticles as drug carriers for malaria
Drugs in nanocapsules ‘recognise’ the infected cells of different types of malaria and could help curb resistance
A study by researchers from the Institute for Bioengineering of Catalonia (IBEC) and the Barcelona Centre for International Health Research (CRESIB) demonstrates that an antimalarial drug encapsulated in nanoparticles—chloroquine salts in polyamidoamine polymers—is significantly more effective when delivered in vivo than free (unencapsulated) drugs and may help to curb drug resistance.